{"id":1215,"date":"2011-06-15T13:25:00","date_gmt":"2011-06-15T13:25:00","guid":{"rendered":"https:\/\/www.novonon.com\/blog\/2011\/06\/15\/in-africa-a-50-cent-vaccine-saves-thousands\/"},"modified":"2011-06-15T13:25:00","modified_gmt":"2011-06-15T13:25:00","slug":"in-africa-a-50-cent-vaccine-saves-thousands","status":"publish","type":"post","link":"https:\/\/www.novonon.com\/blog\/2011\/06\/15\/in-africa-a-50-cent-vaccine-saves-thousands\/","title":{"rendered":"In Africa, a 50-cent vaccine saves thousands"},"content":{"rendered":"<div>\n<\/p>\n<h4>Sent to you via Google Reader<\/h4>\n<h2><a href=\"http:\/\/feedproxy.google.com\/~r\/boingboing\/iBag\/~3\/VhE9m4SsawU\/in-africa-a-50-cent.html\">In Africa, a 50-cent vaccine saves thousands<\/a><\/h2>\n<p>You want &#8220;Wonderful Things,&#8221; I gives ya Wonderful Things. MenAfriVac is a new vaccine for <a href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/\" target=\"_blank\">meningitis A<\/a>\u2014a disease that kills thousands of people in Africa every year.<a href=\"http:\/\/www.newscientist.com\/article\/dn20568-cheap-vaccine-eradicates-new-cases-of-meningitis-a.html\" target=\"_blank\"> It&#8217;s far, far cheaper than previous vaccines &#8230; and it works better, too.<\/a><\/p>\n<blockquote>\n<p>MenAfriVac is much cheaper than existing meningitis A vaccines, at 50\u00a2 compared with $120 per dose. It is also more potent. Unlike conventional vaccines, which are based on sugars resembling those on the surface of Neisseria meningitides, a bacterium that causes meningitis, the new vaccine splices the sugars to a carrier protein that is better at stirring up the body&#8217;s immune system. &#8220;It makes the immune response much more vigorous,&#8221; says Marc LaForce, director of the global Meningitis Vaccine Project, which developed MenAfriVac.<\/p>\n<p>Antibodies against the bacterium continue to be produced long after vaccination, providing hope that a single jab may be enough to give lifelong protection.<\/p>\n<p>So far, no recipient of the vaccine has been infected, and the few cases that have occurred in treated areas were unvaccinated visitors from neighbouring areas.<\/p>\n<\/blockquote>\n<p>MenAfriVac is currently being rolled out in the 25 countries, from Senegal to Sudan, that make up Africa&#8217;s &#8220;meningitis belt.&#8221;<\/p>\n<p><a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=d3f9410560fa92aeabffe72800c95705&#038;p=1\" target=\"_blank\"><img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=d3f9410560fa92aeabffe72800c95705&#038;p=1\"><\/a><br \/><img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" src=\"http:\/\/segment-pixel.invitemedia.com\/pixel?code=TechCons&#038;partnerID=167&#038;key=segment\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" src=\"https:\/\/i0.wp.com\/pixel.quantserve.com\/pixel\/p-8bUhLiluj0fAw.gif?resize=0%2C0\"><img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" src=\"http:\/\/amch.questionmarket.com\/adsc\/d887846\/17\/909940\/adscout.php\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/boingboing\/iBag\/~4\/VhE9m4SsawU\" height=\"1\" width=\"1\"><\/p>\n<\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sent to you via Google Reader In Africa, a 50-cent vaccine saves thousands You want &#8220;Wonderful Things,&#8221; I gives ya Wonderful Things. MenAfriVac is a new vaccine for meningitis A\u2014a disease that kills thousands of people in Africa every year. It&#8217;s far, far cheaper than previous vaccines &#8230; and it works better, too. MenAfriVac is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-1215","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3pfIY-jB","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/posts\/1215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/comments?post=1215"}],"version-history":[{"count":0,"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/posts\/1215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/media?parent=1215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/categories?post=1215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novonon.com\/blog\/wp-json\/wp\/v2\/tags?post=1215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}